Ironwood Pharmaceuticals, Inc. (IRWD)
4.125
-0.16
(-3.85%)
USD |
NASDAQ |
Aug 24, 16:00
4.14
+0.02
(+0.36%)
After-Hours: 20:00
Ironwood Pharmaceuticals Total Liabilities (Quarterly) : 446.97M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 446.97M |
| March 31, 2026 | 651.71M |
| December 31, 2025 | 658.74M |
| September 30, 2025 | 660.22M |
| June 30, 2025 | 651.11M |
| March 31, 2025 | 661.27M |
| December 31, 2024 | 652.24M |
| September 30, 2024 | 700.85M |
| June 30, 2024 | 717.35M |
| March 31, 2024 | 769.34M |
| December 31, 2023 | 817.37M |
| September 30, 2023 | 849.74M |
| June 30, 2023 | 950.00M |
| March 31, 2023 | 448.42M |
| December 31, 2022 | 448.14M |
| September 30, 2022 | 449.28M |
| June 30, 2022 | 442.81M |
| March 31, 2022 | 565.60M |
| December 31, 2021 | 521.02M |
| September 30, 2021 | 499.43M |
| June 30, 2021 | 495.46M |
| March 31, 2021 | 489.15M |
| December 31, 2020 | 496.60M |
| September 30, 2020 | 486.42M |
| June 30, 2020 | 480.39M |
| Date | Value |
|---|---|
| March 31, 2020 | 475.56M |
| December 31, 2019 | 496.00M |
| September 30, 2019 | 487.39M |
| June 30, 2019 | 535.09M |
| March 31, 2019 | 600.72M |
| December 31, 2018 | 528.42M |
| September 30, 2018 | 613.95M |
| June 30, 2018 | 662.17M |
| March 31, 2018 | 589.15M |
| December 31, 2017 | 595.83M |
| September 30, 2017 | 642.66M |
| June 30, 2017 | 700.21M |
| March 31, 2017 | 671.68M |
| December 31, 2016 | 643.10M |
| September 30, 2016 | 672.52M |
| June 30, 2016 | 618.83M |
| March 31, 2016 | 512.39M |
| December 31, 2015 | 524.00M |
| September 30, 2015 | 512.97M |
| June 30, 2015 | 513.66M |
| March 31, 2015 | 237.37M |
| December 31, 2014 | 244.96M |
| September 30, 2014 | 238.02M |
| June 30, 2014 | 229.23M |
| March 31, 2014 | 229.93M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AbbVie, Inc. | 141.00B |
| Rigel Pharmaceuticals, Inc. | 95.64M |
| Marker Therapeutics, Inc. | 2.42M |
| Verastem, Inc. | 156.52M |
| Theriva Biologics, Inc. | 22.67M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 285.13M |
| Shareholders Equity (Quarterly) | -161.84M |
| Debt to Equity Ratio | -2.452 |
| Current Ratio | 6.063 |
| Net Debt Paydown Yield | 5.81% |